The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized clinical trial comparing the efficacy of neoadjuvant chemotherapy and standard treatment in patients with locally advanced colon cancer: The NeoCol trial.
 
Lars Henrik Jensen
Research Funding - 2cureX (Inst); BMS (Inst); Incyte (Inst); MSD (Inst)
Travel, Accommodations, Expenses - MSD
 
Monica Linda Kjaer
No Relationships to Disclose
 
Finn Ole Larsen
No Relationships to Disclose
 
Niels Henrik Hollander
No Relationships to Disclose
 
Hans B. Rahr
No Relationships to Disclose
 
Frank Pfeffer
Stock and Other Ownership Interests - Intuitive Surgical
Research Funding - Intuitive Surgical
 
Laura Diness
No Relationships to Disclose
 
Jan Lindebjerg
No Relationships to Disclose
 
Soeren Rafael Rafaelsen
No Relationships to Disclose
 
Torben Hansen
No Relationships to Disclose
 
Signe Timm
Stock and Other Ownership Interests - Novo Nordisk
 
Inger Marie Løes
Honoraria - SERVIER
Research Funding - Incyte
 
Ismail Gögenur
No Relationships to Disclose
 
Kim Wedervang
No Relationships to Disclose
 
Fahimeh Andersen
Stock and Other Ownership Interests - Novo Nordisk (I)
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - SERVIER
 
Lone Nørgård Petersen
Employment - Novo Nordisk (I)
 
Elinor Bexe Lindskog
Travel, Accommodations, Expenses - Medtronic
 
Laurids Poulsen
Travel, Accommodations, Expenses - MSD
 
Olav Dahl
No Relationships to Disclose